Literature DB >> 15815962

The expanding role of interventional radiology in the supportive care of the oncology patient: from diagnosis to therapy.

Douglas M Coldwell1, Patrick E Sewell.   

Abstract

Interventional radiology (IR) plays an increasing role in the supportive care of the cancer patient from the placement of catheters to treating the offending tumor via image-guided methods. These methods entail the use of both local and regional means, with thermal ablative technology comprising the former and intra-arterial embolization with radioactive particles the latter. Direct placement of the radiofrequency or cryotherapy probes into tumors that are accessible using computed tomography (CT), ultrasound, or magnetic resonance imaging (MRI) guidance provides reliable symptomatic relief of single or multiple tumors in liver, kidney, lung, bone, or soft tissue. Combined with systemic chemotherapy, these techniques increase patient survival. Intra-arterial delivery of radioactive particles to unresectable tumors both provides symptomatic relief and extends survival when combined with current systemic chemotherapy. These new approaches allow IR to provide crucial therapy for cancer patients.

Entities:  

Mesh:

Year:  2005        PMID: 15815962     DOI: 10.1053/j.seminoncol.2004.11.018

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  7 in total

1.  Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.

Authors:  Andrew S Kennedy; David Ball; Steven J Cohen; Michael Cohn; Douglas M Coldwell; Alain Drooz; Eduardo Ehrenwald; Samir Kanani; Steven C Rose; Charles W Nutting; Fred M Moeslein; Michael A Savin; Sabine Schirm; Samuel G Putnam; Navesh K Sharma; Eric A Wang
Journal:  J Gastrointest Oncol       Date:  2015-04

Review 2.  The Role of Palliative Care in Oncology.

Authors:  Rajiv Agarwal; Andrew S Epstein
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

3.  Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancer.

Authors:  Andrew S Kennedy; David Ball; Steven J Cohen; Michael Cohn; Douglas M Coldwell; Alain Drooz; Edward Ehrenwald; Samir Kanani; Fred M Moeslein; Charles W Nutting; Samuel G Putnam; Steven C Rose; Michael Savin; Sabine Schirm; Navesh K Sharma; Eric Wang
Journal:  J Gastrointest Oncol       Date:  2017-02

4.  Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases.

Authors:  Andrew S Kennedy; David S Ball; Steven J Cohen; Michael Cohn; Douglas M Coldwell; Alain Drooz; Eduardo Ehrenwald; Samir Kanani; Charles W Nutting; Fred M Moeslein; Samuel G Putnam; Steven C Rose; Michael A Savin; Sabine Schirm; Navesh K Sharma; Eric A Wang
Journal:  J Gastrointest Oncol       Date:  2015-12

5.  Efficacy and safety of guidewireless catheterization with a steerable microcatheter in patients scheduled for yttrium-90 radioembolization: a prospective multicenter trial.

Authors:  Zbigniew Serafin; Olivier Dudeck; Maciej Powerski; Florian Wolf; Ralph Drewes; Maciej Pech
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-01-21       Impact factor: 1.195

6.  Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases.

Authors:  Andrew Kennedy; Michael Cohn; Douglas M Coldwell; Alain Drooz; Eduardo Ehrenwald; Adeel Kaiser; Charles W Nutting; Steven C Rose; Eric A Wang; Michael A Savin
Journal:  J Gastrointest Oncol       Date:  2017-08

Review 7.  Precision Imaging Guidance in the Era of Precision Oncology: An Update of Imaging Tools for Interventional Procedures.

Authors:  Chiara Floridi; Michaela Cellina; Giovanni Irmici; Alessandra Bruno; Nicolo' Rossini; Alessandra Borgheresi; Andrea Agostini; Federico Bruno; Francesco Arrigoni; Antonio Arrichiello; Roberto Candelari; Antonio Barile; Gianpaolo Carrafiello; Andrea Giovagnoni
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.